scores assigned to the specific percentage luminal diameter reduction of the coronary artery segment are 32 for 100%, 16 for 99%, 8 for 90%, 4 for 75%, 2 for 50%, and 1 for 25%.
ACC/AHA Score [4] [5] [6] Coronary artery score equals the sum of all segment scores (each segment score equals weighting factor multiplied by severity score). Severity scores assigned to the specific percentage luminal diameter reduction of the coronary artery segment are 4 for 90-100%, 3 for 75-89%, 2 for 50-74%, 1 for 10-49%, and 0 for <10%. Second diagonal branch, or obtuse marginal, or distal left anterior descending, and left anterior descending septal perforators with luminal diameter larger than any other artery included in the ACC/ AHA score replaced the artery with the smallest diameter.
Coronary stenoses severity of patients was quantified by the 3 coronary scores, which were calculated on the basis of the angiographic results. Two researchers (Gang Huang, Jiang-long Zhao) calculated the scores separately and the final check was made independently by a third researcher (Yue-hui Yin). Patients who did not visit the outpatient clinic were followed with detailed telephone interview by medical staff (Gang Huang, Jiang-long Zhao). During followup, the emphasis was on symptoms and signs related to MACE or clinical restenosis, such as chest pain, unexplained dyspnea, edema, or new neurological deficit. MACE included cardiogenic death, stroke, heart failure, nonfatal myocardial infarction (MI), and rehospitalization for angina pectoris. All MACE were verified by medical records or confirmed by the physician in charge.
Follow-up and Endpoints

Statistical Analysis
Patient demographic characteristics are presented as medians and interquartile ranges for continuous variables, and as proportions (percentages) for categorical variables. The association of each coronary score with clinical outcomes (cardiogenic death, stroke, heart failure) was assessed by multivariable logistic regression. Separate multivariable Cox proportional hazards regression models were used to assess the association of each coronary score with MACE. Receiver-operating characteristic (ROC) curves for prediction of MACE were used to demonstrate the sensitivity and specificity of each coronary score. Statistical comparisons were performed with SPSS 15.0 for Windows (Chicago, IL, USA). Nominal significance was taken as a 2-tailed P-value <0.05.
Results
Baseline Clinical Characteristics
Patient clinical characteristics are presented in Table 2 . Of the 958 participants with ACS, 67.5% were males. The median age was 69 years (range 60-78); 58.4% of the study population had a history of hypertension, 25.6% had diabetes mellitus, and 28.2% were smokers. The main angiographic findings are presented in Table 3 . More than 50% of the patients had stenosis of the left anterior descending artery and right coronary artery. Most of the lesions were moderate risk. 
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Coronary Scores With Clinical Outcomes
The mean follow-up was 26.4 months (range 1-116). Clinical outcomes of the patients are shown in Table 4 : 257 patients reached the endpoints, comprising 37 cardiogenic deaths, 12 strokes, 72 heart failures, 14 nonfatal MIs, and 122 rehospitalizations for angina pectoris. By entering the history of smoking, diabetes mellitus, the admission levels of serum creatinine, cardiac troponin (cTnT), and glucose, and the Gensini score, the multivariable Cox proportional hazards regression analysis model revealed that the Gensini score was independently associated with 90-day MACE (P=0.004), 6-month MACE (P<0.001), 1-year MACE (P=0.002), and MACE during follow-up (P=0.040) in patients with angiographic ACS. When the same multivariable Cox proportional hazards regression analysis model included the Leaman score, it revealed an independent association with 90-day MACE (P=0.014), 6-month MACE (P=0.002), and 1-year MACE (P=0.009), whereas the ACC/AHA score was not associated with all-phase MACE during follow-up (Table 5) .
By logistic regression analysis (entering the histories of hypertension, diabetes mellitus and smoking, admission levels of glucose, cTnT, serum creatinine, and low-density lipoprotein (LDL), use of aspirin, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers or statins, and Gensini score), the Gensini score was independently associated with cardiogenic death (P=0.001) and stroke (P= 0.046), whereas the Leaman score was independently associated with cardiogenic death (P=0.007) and the ACC/AHA score was independently associated with cardiogenic death (P=0.025) and stroke (P=0.050) ( Table 6 ).
Comparison of Scores
ROC analysis was performed to test the sensitivity and specificity of the 3 coronary scores for MACE. The area under the ROC curve (AUC) for each score is shown in Table 7 .
The AUC for the Gensini score was 0.736 (95% confidence interval (CI) 0.699-0.771, P<0.001) and 0.582 (95%CI 0.542-0.621, P=0.4408) for cardiogenic death and stroke, respectively; for the Leaman score it was 0.737 (95%CI 0.700-0.771, P<0.001) for cardiogenic death; and for the ACC/AHA score it was 0.692 (95%CI 0.654-0.729, P=0.0026) and 0.499 (95%CI 0.458-0.539, P=0.9903) for cardiogenic death and stroke, respectively.
No statistical differences between the Gensini and Leaman scores for all-phase MACE were observed (Figures A-C) . The ROC curves of the 3 coronary scores for cardiogenic death were not statistically different ( Figure D) .
Discussion
The main findings of this study of patients with ACS are as follows. (1) The Gensini score is associated with short-and The purpose of the coronary scoring systems is to quantify the severity of coronary stenoses. Different coronary arteries carry different volumes of blood to the heart, and all the coronary scores take this into account. The degree of stenosis was also considered in deriving the scores. Compared with using the number of diseased coronary vessels to judge the severity of CVD, the coronary score systems more effectively reflect the severity of coronary stenoses, because they are based on more detailed information provided by coronary angiography.
Both the Leaman and Gensini scores concentrate on the left main coronary artery, proximal left anterior descending, and mid-left anterior descending arteries, which are assigned relatively higher weighting factors. Both scores account for more coronaries arteries, not only the major vessels but also their braches. All arteries are weighted 1 in the ACC/AHA score, whereas in the Leaman and Gensini scores, arteries are weighted according to their relative importance in supplying different volumes of blood to the myocardium.
Assessing a person's cardiovascular risk is widely accepted in clinical practice. Patients who are asymptomatic but at high risk of CVD may benefit from preventive treatment. The Gensini score has been widely used in clinical trails to assess the extent and severity of coronary stenoses, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] whereas the Leaman and ACC/AHA scores are not. In our study, all 3 coronary scores were used as independent variables to investigate the impact of each score on MACE in patients with ACS, while most of the other studies have used the Gensini score as a dependent variable in statistical models to describe and judge the severity of coronary stenoses. Although all 3 coronary scores are derived from selective angiography for assessing the severity of coronary stenoses, their associations with MACE in patients with ACS differ. The Gensini score displays the closest association with MACE in ACS, and the Leaman score has a closer association with MACE than the ACC/AHA score, according to our study. Assessing risk is paramount in achieving treatment success. Clinical risk scores based on information such as clinical presentation, history and laboratory test results could prevent adverse outcomes. Though new advanced methods such as 64-slice multidetector computed tomography 17, 18 and single-photon emission computed tomography 19 have been introduced into the practice of clinical cardiology, selective coronary angiography as an invasive procedure provides the most reliable anatomical and functional information. There are many clinical risk scores, such as FRS, 20 TIMI score 21, SCORE, 22 and the GRACE score, 23 etc, but few risk scores 19 include coronary angiography findings to enable risk stratification. However, the valuable detailed information from angiography is not sufficiently used in clinical practice. As a continuous process from admission through discharge, risk stratification should be updated with further data obtained during the hospital stay. A combination of basic clinical factors and coronary scores may be a good choice for physicians to judge the overall risk of patients. The results of our study could help clinicians prioritize coronary scores and thus evaluate quantitatively the severity of coronary disease.
Study Limitations
The study population was relatively small and the results cannot yet be extrapolated to patients other than those with ACS. Therefore, any findings of this study should be applied in clinical practice with caution. Some factors improving prognosis, such as preventive medication advancing, might reasonably cause bias. Coronary scores can evaluate lesion severity only by luminal stenosis not by plaque vulnerability, which is important for the whole coronary artery in ACS.
Conclusion
In conclusion, in patients with ACS the Gensini score provides more valuable prognostic information on cardiovascular risk than either the Leaman or ACC/AHA score. 
